Evaluation of Salivary Interleukin-1 Beta in Covid Recovered Patients
Harini Palani, Palati Sinduja, R. Priyadharshini & V. Meghashree · Journal of Pharmaceutical Research International · 2021
Introduction: The COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The epidemic started in Wuhan in mid-December 2019 and quickly spread across the world as a pandemic. Saliva is emerging as a promising alternative to nasopharyngeal/oropharyngea...
Open access
Research Article
10.9734/jpri/2021/v33i57A33999